The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
Jack Smith withheld names from judges who greenlit GOP lawmakers’ phone records access
Trump tells Colorado governor and district attorney to ‘rot in Hell’ over Tina Peters incarceration
Germany’s Merz says Europe must ‘defend and assert’ interests amid ‘changing’ relations with US
Somali daycare in Minnesota broken into, key documents stolen in overnight burglary
Blue cities U-turn on distributing drug supplies to addicts after progressive policies fail to stem epidemic
President Trump Has a Backup Plan if the Supreme Court Strikes Down His Tariffs
Treasury targets oil traders, tankers accused of helping Maduro evade U.S. sanctions
Ex-police officer given prison time in case prosecuted under Soros DA sees conviction overturned a year later
Trump Presides Over the Largest One-Year Drop in Homicides Ever Recorded
CNN Finally Shows Up at Minneapolis Day Care, But for All the Wrong Reasons
Why the Times Square Ball Will Drop Twice This Year for the First Time Ever
San Francisco mayor quietly signs reparations fund that could lead to $5M payments per person
Boebert hits back at Trump after veto of Colorado water bill, raises retaliation concerns
Unseen Walmart video shows Bryan Kohberger acting differently after Idaho student murders
Comer, House Oversight demand answers in Minnesota fraud hearing, call on Walz to testify
HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”
Jack Smith withheld names from judges who greenlit GOP lawmakers’ phone records access
Trump tells Colorado governor and district attorney to ‘rot in Hell’ over Tina Peters incarceration
Germany’s Merz says Europe must ‘defend and assert’ interests amid ‘changing’ relations with US
Somali daycare in Minnesota broken into, key documents stolen in overnight burglary
Blue cities U-turn on distributing drug supplies to addicts after progressive policies fail to stem epidemic
President Trump Has a Backup Plan if the Supreme Court Strikes Down His Tariffs
Treasury targets oil traders, tankers accused of helping Maduro evade U.S. sanctions
Ex-police officer given prison time in case prosecuted under Soros DA sees conviction overturned a year later
Trump Presides Over the Largest One-Year Drop in Homicides Ever Recorded
CNN Finally Shows Up at Minneapolis Day Care, But for All the Wrong Reasons
Why the Times Square Ball Will Drop Twice This Year for the First Time Ever
San Francisco mayor quietly signs reparations fund that could lead to $5M payments per person
Boebert hits back at Trump after veto of Colorado water bill, raises retaliation concerns
Unseen Walmart video shows Bryan Kohberger acting differently after Idaho student murders
Comer, House Oversight demand answers in Minnesota fraud hearing, call on Walz to testify
President Donald Trump has suggested that hydroxychloroquine could be effective, and has encouraged further study. His interest in the drug has prompted pushback from the media.
NBC News’ Peter Alexander accused the president last week of giving Americans “false hope,” and Politico’s Dan Diamond reported Sunday that the FDA decision came despite “scant evidence,” adding that “[c]areer scientists have been skeptical of the effort.”
Story cited here.
